GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Vaccine Biologics Corp (ROCO:6547) » Definitions » Cash Flow for Lease Financing

Medigen Vaccine Biologics (ROCO:6547) Cash Flow for Lease Financing : NT$-13.8 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Medigen Vaccine Biologics Cash Flow for Lease Financing?

Medigen Vaccine Biologics's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was NT$-4.0 Mil. Medigen Vaccine Biologics's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-13.8 Mil.

Compared with last quarter (NT$-3.2 Mil in Dec. 2024 ), Medigen Vaccine Biologics's Cash Flow for Lease Financing remained the same in Mar. 2025 (NT$-4.0 Mil).


Medigen Vaccine Biologics Cash Flow for Lease Financing Historical Data

The historical data trend for Medigen Vaccine Biologics's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Vaccine Biologics Cash Flow for Lease Financing Chart

Medigen Vaccine Biologics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.59 -1.93 -11.56 -11.78 -12.81

Medigen Vaccine Biologics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.00 -2.99 -3.59 -3.22 -4.03

Medigen Vaccine Biologics Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-13.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medigen Vaccine Biologics Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Medigen Vaccine Biologics's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Medigen Vaccine Biologics Business Description

Traded in Other Exchanges
N/A
Address
No.68, Shengyi 3rd Road, Hsinchu County, Zhubei, TWN, 30261
Medigen Vaccine Biologics Corp is a biopharmaceutical company focusing on developing and producing vaccines and biologics. It is engaged in developing IP-protected cell-culture technologies for vaccine manufacturing. The company develops vaccines and affordable biosimilars to prevent regional infectious diseases. The group generates revenue from manufacturing and selling a range of COVID-19 vaccines and COVID-19 test kits and provides technical services on cellular therapy product quality and cell culture tests.

Medigen Vaccine Biologics Headlines

No Headlines